SCHEMBL3968244

SCHEMBL3968244

CC(=O)C(Nc1cc(-c2cccnc2)nc(-c2ccccn2)n1)N1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MKNK1 Q9BUB5 1/20 0.40
MKNK2 Q9HBH9 1/20 0.40
CYP2A6 P11509 1/20 0.39
ADORA2A P29274 3/20 0.39
ADORA1 P30542 3/20 0.39
CYP1A2 P05177 2/20 0.39
F2 P00734 1/20 0.38
F12 P00748 1/20 0.38
KARS1 Q15046 2/20 0.38
ABL1 P00519 2/20 0.38
KIT P10721 2/20 0.38
BCR P11274 1/20 0.38
LRRK2 Q5S007 1/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.38
TSHR P16473 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
ABL2 P42684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2235626 0.76 HDAC1 (0.48) MKNK1MKNK2HDAC1
SCHEMBL4771872 0.74 CYP2A6 (0.45) CYP2A6ADORA2AADORA1CYP1A2ABL1
SCHEMBL4777383 0.73 METAP1 (0.47) HDAC1
SCHEMBL4774839 0.73 DYRK1A (0.51) CYP2A6ADORA2AADORA1CYP1A2NPC1
SCHEMBL4766345 0.73 CYP2A6 (0.46) CYP2A6CYP1A2F2F12NPC1
SCHEMBL4766379 0.73 CYP2A6 (0.46) CYP2A6CYP1A2F2F12NPC1
SCHEMBL4767685 0.73 ADORA1 (0.47) ADORA2AADORA1
SCHEMBL4775851 0.71 PIM1 (0.45) CYP1A2KARS1KITHTR1AHTR7
SCHEMBL3962124 0.71 CYP2A6 (0.46) CYP2A6ADORA2ACYP1A2NPC1TP53
SCHEMBL3962923 0.71 CYP2A6 (0.43) CYP2A6ADORA2ACYP1A2NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2044056-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS Novartis Ag (CH) 2009-04-08 EP claimed
WO-2008006583-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS NOVARTIS AG (CH) 2008-01-17 WO claimed
EP-2044056-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS Novartis Ag (CH) 2009-04-08 EP disclosed
WO-2008006583-A1 PYRIMIDINE DERIVATIVES AS ALK-5 INHIBITORS NOVARTIS AG (CH) 2008-01-17 WO disclosed